The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Early estimates of nirsevimab immunoprophylaxis effectiveness against hospital admission for respiratory syncytial virus lower respiratory tract infections in infants, Spain, October 2023 to January 2024
Open accessAbstract
The monoclonal antibody nirsevimab was at least 70% effective in preventing hospitalisations in infants with lower respiratory tract infections (LRTI) positive for respiratory syncytial virus (RSV) in Spain (Oct 2023–Jan 2024), where a universal immunisation programme began late September (coverage range: 79–99%). High protection was confirmed by two methodological designs (screening and test-negative) in a multicentre active surveillance in nine hospitals in three regions. No protection against RSV-negative LRTI-hospitalisations was shown. These interim results could guide public-health decision-making.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The test-negative design for estimating influenza vaccine effectiveness
Jackson, M. L., & Nelson, J. C. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.02.053 · Cited by 510
Parikh, S. R., Andrews, N. J., Beebeejaun, K., Campbell, H., Ribeiro, S., Ward, C., White, J. M., Borrow, R., Ramsay, M. E., & Ladhani, S. N. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31921-3 · Cited by 275
Cited by
COVID-19 Outbreak: An Overview
Ciotti, M., Angeletti, S., Minieri, M., Giovannetti, M., Benvenuto, D., Pascarella, S., Sagnelli, C., Bianchi, M., Bernardini, S., & Ciccozzi, M. (2019) · Chemotherapy · doi:10.1159/000507423 · Cited by 430
Ares-Gómez, S., Mallah, N., Santiago-Pérez, M.-I., Pardo-Seco, J., Pérez-Martínez, O., Otero-Barrós, M.-T., Suárez-Gaiche, N., Kramer, R., Jin, J., Platero-Alonso, L., et al. (2024) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(24)00215-9 · Cited by 254
Metadata
- Authors
- López-Lacort, M., Muñoz-Quiles, C., Mira-Iglesias, A., López-Labrador, F. X., Mengual-Chuliá, B., Fernández-García, C., Carballido-Fernández, M., Pineda-Caplliure, A., Mollar-Maseres, J., Shalabi Benavent, M., Sanz-Herrero, F., Zornoza-Moreno, M., Pérez-Martín, J. J., Alfayate-Miguelez, S., Pérez Crespo, R., Bastida Sánchez, E., Menasalvas-Ruiz, A. I., Téllez-González, M. C., Esquiva Soto, S., Del Toro Saravia, C., Sanz-Muñoz, I., Eiros, J. M., Matías Del Pozo, V., Toquero-Asensi, M., Pastor-Villalba, E., Lluch-Rodrigo, J. A., Díez-Domingo, J., & Orrico-Sánchez, A.
- Venue
- Eurosurveillance
- Published
- 2024-02-08
- Volume
- 29
- Issue
- 6
- ISSN
- 1025-496X (ISSN-L)
- 1560-7917
- OpenAlex
- W4391683735
- Cited by
- 194
- References
- 2
- FWCI
- 47.33
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Early estimates of nirsevimab immunoprophylaxis effectiveness against hospital admission for respiratory syncytial virus lower respiratory tract infections in infants, Spain, October 2023 to January 2024. https://app.cochat.ai/papers/10.2807/1560-7917.es.2024.29.6.2400046
- The paper
- López-Lacort, M., Muñoz-Quiles, C., Mira-Iglesias, A., López-Labrador, F. X., Mengual-Chuliá, B., Fernández-García, C., Carballido-Fernández, M., Pineda-Caplliure, A., Mollar-Maseres, J., Shalabi Benavent, M., Sanz-Herrero, F., Zornoza-Moreno, M., Pérez-Martín, J. J., Alfayate-Miguelez, S., Pérez Crespo, R., Bastida Sánchez, E., Menasalvas-Ruiz, A. I., Téllez-González, M. C., Esquiva Soto, S., . . . Orrico-Sánchez, A. (2024). Early estimates of nirsevimab immunoprophylaxis effectiveness against hospital admission for respiratory syncytial virus lower respiratory tract infections in infants, Spain, October 2023 to January 2024. Eurosurveillance. https://doi.org/10.2807/1560-7917.es.2024.29.6.2400046
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.